Application of Native ESI-MS to Characterize Interactions between Compounds Derived from Fragment-Based Discovery Campaigns and Two Pharmaceutically Relevant Proteins. (October 2018)
- Record Type:
- Journal Article
- Title:
- Application of Native ESI-MS to Characterize Interactions between Compounds Derived from Fragment-Based Discovery Campaigns and Two Pharmaceutically Relevant Proteins. (October 2018)
- Main Title:
- Application of Native ESI-MS to Characterize Interactions between Compounds Derived from Fragment-Based Discovery Campaigns and Two Pharmaceutically Relevant Proteins
- Authors:
- Gavriilidou, Agni F. M.
Holding, Finn P.
Coyle, Joseph E.
Zenobi, Renato - Abstract:
- Native electrospray ionization mass spectrometry (ESI-MS) was applied to analyze the binding of compounds generated during fragment-based drug discovery (FBDD) campaigns against two functionally distinct proteins, the X-linked inhibitor of apoptosis protein (XIAP) and cyclin-dependent kinase 2 (CDK2). Compounds of different molecular weights and a wide range of binding affinities obtained from the hits to leads and lead optimization stages of FBDD campaigns were studied, and their dissociation constants (Kd ) were measured by native ESI-MS. We demonstrate that native ESI-MS has the potential to be applied to the stages of an FBDD campaign downstream of primary screening for the detection and quantification of protein–ligand binding. Native ESI-MS was used to derive Kd values for compounds binding to XIAP, and the dissociation of the complex between XIAP and a peptide derived from the second mitochondria-derived activator of caspases (SMAC) protein induced by one of the test compounds was also investigated. Affinities of compounds binding to CDK2 gave Kd values in the low nanomolar to low millimolar range, and Kd values generated by MS and isothermal titration calorimetry (ITC) followed the same trend for both proteins. Practical considerations for the application of native ESI-MS are discussed in detail.
- Is Part Of:
- SLAS discovery. Volume 23:Number 9(2018)
- Journal:
- SLAS discovery
- Issue:
- Volume 23:Number 9(2018)
- Issue Display:
- Volume 23, Issue 9 (2018)
- Year:
- 2018
- Volume:
- 23
- Issue:
- 9
- Issue Sort Value:
- 2018-0023-0009-0000
- Page Start:
- 951
- Page End:
- 959
- Publication Date:
- 2018-10
- Subjects:
- native mass spectrometry -- fragment-based drug discovery -- noncovalent interactions
Drugs -- Analysis -- Periodicals
Drugs -- Testing -- Periodicals
Biomolecules -- Analysis -- Periodicals
Biomolecules -- Analysis
Drugs -- Analysis
Drugs -- Testing
Drug Evaluation, Preclinical
Molecular Biology -- methods
Periodicals
Periodicals
615.1 - Journal URLs:
- http://journals.sagepub.com/home/jbx ↗
https://www.sciencedirect.com/journal/slas-discovery/ ↗
http://www.sagepublications.com/ ↗
https://www.journals.elsevier.com/slas-discovery ↗ - DOI:
- 10.1177/2472555218775921 ↗
- Languages:
- English
- ISSNs:
- 2472-5552
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8695.xml